Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Valsartan 160 mg Caplets vs Diovan® 160
NCT02518451Phase 1Completed
- Sponsor
- Dexa Medica
- Start
- Jun 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Dexa Medica. Primary endpoints: Area under the concentration-versus-time curve from time zero to the time of last quantifiable concentration at 48 hours, Area under the concentration-versus-time curve from time zero extrapolated to infinity at 48 hours and 1 more. Started Jun 2013; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02518451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518451.